PAX4 preserves endoplasmic reticulum integrity preventing beta cell degeneration in a mouse model of type 1 diabetes mellitus
Authors:
- Alejandro Martin-MontalvoAlejandro Martin-Montalvo
- Ana Isabel Alvarez-MercadoAAAna Isabel Alvarez-Mercado
- Esther Fuente-MartinEFEsther Fuente-Martin
- Nadia Cobo-VuilleumierNCNadia Cobo-Vuilleumier
- Petra Isabel LorenzoPLPetra Isabel Lorenzo
- Livia López-NoriegaLLLivia López-Noriega
- Javier Santoyo-LópezJSJavier Santoyo-López
Open Access
- 26 January 2016
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 59 (4) , 755-765
Abstract
Aims/hypothesis A strategy to enhance pancreatic islet functional beta cell mass (BCM) while restraining inflammation, through the manipulation of molecular and cellular targets, would provide a means to counteract the deteriorating glycaemic control associated with diabetes mellitus. The aims of the current study were to investigate the therapeutic potential of such a target, the islet-enriched and diabetes-linked transcription factor paired box 4 (PAX4), to restrain experimental autoimmune diabetes (EAD) in the RIP-B7.1 mouse model background and to characterise putative cellular mechanisms associated with preserved BCM. Methods Two groups of RIP-B7.1 mice were genetically engineered to: (1) conditionally express either PAX4 (BPTL) or its diabetes-linked mutant variant R129W (mutBPTL) using doxycycline (DOX); and (2) constitutively express luciferase in beta cells through the use of RIP. Mice were treated or not with DOX, and EAD was induced by immunisation with a murine preproinsulin II cDNA expression plasmid. The development of hyperglycaemia was monitored for up to 4 weeks following immunisation and alterations in the BCM were assessed weekly by non-invasive in vivo bioluminescence intensity (BLI). In parallel, BCM, islet cell proliferation and apoptosis were evaluated by immunocytochemistry. Alterations in PAX4- and PAX4R129W-mediated islet gene expression were investigated by microarray profiling. PAX4 preservation of endoplasmic reticulum (ER) homeostasis was assessed using thapsigargin, electron microscopy and intracellular calcium measurements. Results PAX4 overexpression blunted EAD, whereas the diabetes-linked mutant variant PAX4R129W did not convey protection. PAX4-expressing islets exhibited reduced insulitis and decreased beta cell apoptosis, correlating with diminished DNA damage and increased islet cell proliferation. Microarray profiling revealed that PAX4 but not PAX4R129W targeted expression of genes implicated in cell cycle and ER homeostasis. Consistent with the latter, islets overexpressing PAX4 were protected against thapsigargin-mediated ER-stress-related apoptosis. Luminal swelling associated with ER stress induced by thapsigargin was rescued in PAX4-overexpressing beta cells, correlating with preserved cytosolic calcium oscillations in response to glucose. In contrast, RNA interference mediated repression of PAX4-sensitised MIN6 cells to thapsigargin cell death. Conclusions/interpretation The coordinated regulation of distinct cellular pathways particularly related to ER homeostasis by PAX4 not achieved by the mutant variant PAX4R129W alleviates beta cell degeneration and protects against diabetes mellitus. The raw data for the RNA microarray described herein are accessible in the Gene Expression Omnibus database under accession number GSE62846.Keywords
Funding Information
- Ministerio de Ciencia e Innovación (BFU2013-42789-P to I.Q.)
- consejería de economía, innovación y ciencia (P10.CTS.6359 to B.R.G.)
- Instituto de Salud Carlos III (CP14/00105 to A.M.M., PI10/00871 to B.R.G, PI13/00593 to B.R.G)
- Swiss National Research Foundation (310030-141162 to P.M.)
- European Commission (C2008-T7 to P.M.)
- Lee Kong Chian School of Medicine, Nanyang Technological University (B.O.B.)
- Consejeria de Salud, Fundacion Publica Andaluza Progreso y Salud, Junta de Andalucia (PI-0085-2013 to P.I.L., PI-0727-2010 to B.R.G.)
- Juvenile Diabetes Research Foundation International (17-2013-372 to B.R.G.)
This publication has 46 references indexed in Scilit:
- Pancreatic α Cells are Resistant to Metabolic Stress-induced Apoptosis in Type 2 DiabetesEBioMedicine, 2015
- Pancreatic and duodenal homeobox-1 nuclear localization is regulated by glucose in dispersed rat islets but not in insulin-secreting cell linesIslets, 2014
- Targeting inflammation in the treatment of type 2 diabetes: time to startNature Reviews Drug Discovery, 2014
- Type 2 Diabetes and Congenital Hyperinsulinism Cause DNA Double-Strand Breaks and p53 Activity in β CellsCell Metabolism, 2014
- Destruction of Tissue, Cells and Organelles in Type 1 Diabetic Rats Presented at Macromolecular ResolutionScientific Reports, 2013
- In Vivo Conditional Pax4 Overexpression in Mature Islet β-Cells Prevents Stress-Induced Hyperglycemia in MiceDiabetes, 2011
- Attenuation of Th1 response through galectin‐9 and T‐cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD miceEuropean Journal of Immunology, 2009
- Cytokines Downregulate the Sarcoendoplasmic Reticulum Pump Ca2+ ATPase 2b and Deplete Endoplasmic Reticulum Ca2+, Leading to Induction of Endoplasmic Reticulum Stress in Pancreatic β-CellsDiabetes, 2005
- Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implicationsDiabetologia, 2004
- A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome)Nature Genetics, 1998